Heteronemin and Tetrac Induce Anti-Proliferation by Blocking EGFR-Mediated Signaling in Colorectal Cancer Cells.

Mar Drugs · 2022 · PMC9410344 · PMID 36005485

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Although PI3K mRNA levels did not exhibit any statistically significant difference, a decreasing trend was shown after being treated with heteronemin or tetrac in both cell lines, and by combined treatment in HCT-116 cells ( KRAS MT CRC). 2.7.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.